Nitrocor tablets sublingual 0.5mg, No. 40
Expiration Date: 11/2025
Russian Pharmacy name:
Нитрокор таблетки подъязычные 0.5мг, №40
Relief of angina attacks.
Sublingual.
Nitroglycerin is recommended to be taken as directed by a physician.
The tablet is kept under the tongue until it is completely absorbed, without swallowing, immediately after the onset of pain - 0.5Ц1 mg per dose. In many patients with stable angina pectoris, the effect comes from a lower dose (1 / 2Ц1 / 3 tab.), Therefore, if the pain quickly passes, the rest of the pill, which did not have time to dissolve, is recommended to be spit out. Usually, the antianginal effect appears within 0.5Ц2 minutes; 75% of patients notice improvement within the first 3 minutes, and another 15% - within 4-5 minutes. In the absence of antianginal action, within the first 5 minutes, you need to take another 1 table. nitroglycerin. In the absence of a therapeutic effect after taking 2-3 tablets. you need to call a doctor immediately. The duration of action after sublingual administration is about 45 minutes. With frequent attacks of angina pectoris, it is customary to prescribe prolonged nitroglycerin drugs.Tolerance to sublingual forms of nitroglycerin develops infrequently, nevertheless, when it occurs in some patients, the dose of the drug has to be gradually increased, bringing it to 2-3 tablets.
Sublingual tablets | 1 tab. |
nitroglycerine | 0.5 mg |
excipients: crospovidone CL; lactose; povidone 25; macrogol 6000 |
in a contour acheikova packing 10 or 20 pcs.; in a cardboard box 1, 2, 3, 4, 5, 6, 8 or 10 packages or in polymer containers of 10, 20, 30, 40, 50 or 100 pcs.; in a carton pack 1 container.
hypersensitivity to nitrates;
cranial hypertension;
cardiac tamponade;
isolated mitral stenosis;
constrictive pericarditis (conditions accompanied by a decrease in the filling pressure of the left ventricle);
uncontrolled hypovolemia;
heart failure with normal or low pulmonary artery pressure;
collapse;
hemorrhagic stroke;
subarachnoid hemorrhage;
recent head injury;
toxic pulmonary edema;
idiopathic hypertrophic subaortic stenosis;
angle-closure glaucoma with high intraocular pressure;
severe anemia;
hyperthyroidism;
age up to 18 years (safety of use has not been established);
violation of cerebral circulation;
shock;
arterial hypotension (SBP <90 mm Hg);
concomitant use of sildenafil (Viagra);
pregnancy;
period of breastfeeding.
With caution (balancing risks and benefits):
severe renal failure;
liver failure (risk of developing methemoglobinemia).